BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)

SHA:688166 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 19, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	21,158	12,748	14,786	9,535	15,051	18,778
Market Cap Growth	56.64%	-13.79%	55.07%	-36.65%	-19.85%	44.16%
Enterprise Value	22,976	14,391	15,983	10,606	15,560	18,464
Last Close Price	50.05	30.15	34.85	22.36	36.17	45.02
PE Ratio	340.83	67.39	73.03	39.79	61.70	110.54
Forward PE	84.12	28.00	28.00	28.00	43.06	52.05
PS Ratio	17.93	9.94	12.54	9.37	14.30	23.91
PB Ratio	8.36	5.23	6.12	4.25	8.64	13.11
P/TBV Ratio	8.97	5.54	6.52	4.54	9.47	13.58
P/OCF Ratio	94.07	51.91	75.92	30.63	85.48	120.81
EV/Sales Ratio	19.47	11.22	13.55	10.43	14.79	23.51
EV/EBITDA Ratio	126.15	48.52	58.11	39.13	54.92	86.56
EV/EBIT Ratio	-	71.68	76.75	45.84	62.45	100.84
Debt / Equity Ratio	0.93	0.92	0.91	0.90	0.52	0.15
Debt / EBITDA Ratio	12.85	7.20	7.71	7.17	3.10	1.03
Asset Turnover	0.23	0.25	0.24	0.27	0.44	0.48
Inventory Turnover	1.62	1.58	1.74	1.63	2.33	2.14
Quick Ratio	0.81	1.06	1.49	1.92	1.23	2.39
Current Ratio	1.26	1.56	2.00	2.39	1.70	3.24
Return on Equity (ROE)	1.06%	5.82%	7.44%	10.62%	14.97%	12.34%
Return on Assets (ROA)	0.62%	2.46%	2.69%	3.79%	6.49%	7.04%
Return on Capital (ROIC)	0.67%	2.70%	2.93%	4.19%	7.25%	7.72%
Return on Capital Employed (ROCE)	1.20%	4.90%	5.10%	6.00%	10.40%	11.90%
Earnings Yield	0.29%	1.48%	1.37%	2.51%	1.62%	0.91%
FCF Yield	-0.68%	-0.09%	-1.41%	-4.36%	-4.87%	-1.06%
Dividend Yield	0.19%	0.32%	0.27%	0.51%	0.33%	0.19%
Payout Ratio	176.87%	71.75%	56.80%	41.77%	22.26%	20.84%
Buyback Yield / Dilution	0.21%	0.34%	-2.10%	-1.61%	1.87%	-11.90%
Total Shareholder Return	0.41%	0.66%	-1.82%	-1.10%	2.21%	-11.71%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.